Latest Breaking News On - Drug administration for emergency use authorization - Page 8 : comparemela.com
Romark’s investigational Covid-19 drug lowers disease progression in trial 15th April 2021 (Last Updated April 15th, 2021 17:33)
Romark has reported that initial results from a Phase III clinical trial of its investigational new drug candidate NT-300 (nitazoxanide extended-release tablets, 300mg) demonstrated to reduce disease progression in mild or moderate Covid-19 patients.
The trial enrolled 1,092 subjects aged 12 years and above with respiratory symptoms consistent with Covid-19. Credit: Ewa Urban from Pixabay.
Share Article
Romark has reported that initial results from a Phase III clinical trial of its investigational new drug candidate NT-300 (nitazoxanide extended-release tablets, 300mg) demonstrated to reduce disease progression in mild or moderate Covid-19 patients.
Drug-administration-for-emergency-use-authorizationDrug-administrationEmergency-use-authorizationஅவசரம்-பயன்பாடு-அங்கீகாரம்